ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Obesity
This article is part of the Research TopicHyperphagia in Syndromic and Hypothalamic Obesity: Mechanisms, Consequences, and InterventionsView all 3 articles
Dietary Medium Chain Triglycerides Impairs Orexigenic Action of Ghrelin in Mice
Provisionally accepted- 1Department of Gastroenterology and Metabolism, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan
- 2Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan
- 3Center for Diabetes, Endocrinology and Metabolism, Shizuoka General Hospital, Shizuoka, Japan
- 4Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Ghrelin, a stomach-derived hormone, increases food intake and body weight. Efforts have been made therefore to modulate ghrelin signaling for the treatment of obesity or emaciation. However, basic biology of the potential effects of dietary nutrients on ghrelin action has not yet been fully uncovered. To investigate an impact of fat intake on orexigenic effect of ghrelin, we examined ghrelin transgenic mice or mice treated with ghrelin fed with the diet containing medium-chain triglycerides (MCT). Five-day MCT diet feeding increased plasma ghrelin levels by 2.5-fold compared with long-chain triglyceride (LCT)-fed mice, potentially through O-acyltransferase-mediated medium-chain fatty acylation and maturation of ghrelin. The plasma ghrelin levels of ghrelin and O-acyltransferase double transgenic mice (ghrelin-Tg) reached ten times higher than wild-type (WT) littermates under the MCT diet. The rise of plasma ghrelin levels in ghrelin-Tg, however, was not associated with any changes in food intake or body weight. Administration of ghrelin significantly increased food intake in WT mice under the normal chow (NC) or the LCT diet. In contrast, ghrelin-induced increase of food intake was not observed under the MCT diet. Consistently, upregulation of hypothalamic expression of neuropeptide Y (NPY), a critical mediator of orexigenic action by ghrelin, was observed under the NC or the LCT diet, but not under the MCT diet. Meanwhile, enhancement of food intake by the intracerebroventricular injection of NPY was preserved in mice fed with the MCT diet, suggesting an interference of ghrelin signaling upstream of NPY. Interestingly, ghrelin-induced growth hormone (GH) secretion was not attenuated by the MCT diet, indicating a distinct pathway for appetite and GH regulation. Our results provide evidence for the MCT-induced attenuation of the orexigenic effect of ghrelin, and suggest a novel interplay between dietary lipids and hormone signaling.
Keywords: Ghrelin, medium-chain triglycerides, food intake, hormone signaling, Growth Hormone
Received: 22 Aug 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Aotani, Ariyasu, Tanaka, Shimatsu-Kuwahara, Nomura, Shimizu, Takeda, Koyama, Kusakabe, Miyazawa, Hikida, Kataoka and Nakao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Daisuke Aotani
Hiroyuki Ariyasu
Tomohiro Tanaka
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
